Pluristem Therapeutics Inc (PSTI)

[skitahoe]

I won't disagree that their is competition on CLI, but I believe our results are good from what I've read, but also that more than one approval can result from trials, and often multiple drugs may prove to be the best answer.

It's possible that substantial dilution will be needed by 2020, but it's also very possible that either a partnership, or major grant or sale to perhaps the DOD might provide the needed financial support.

Dilution is a fact of life in emerging companies everywhere, it's certainly not exclusive to this company. I don't believe it would be nearly as opposed if the share price were between $5 and $10 than if it occurred today, and I believe as more data comes in, much greater stock prices will be achieved.

Gary